Prostatype Genomics AB: Rights issue registered and trading in paid subscription units ceases
2024-01-16 09:30 Prostatype Genomics AB ("Prostatype Genomics" or the "Company") has completed a rights issue of units, consisting of shares and warrants of series 3, that closed on January 5, 2024. The rights issue is now registered with the Swedish Companies Registration Office and the last day of trading in paid subscription units (“BTU”) is January 17, 2024. The record date is January 19, 2024, after which BTUs are converted into shares and warrants of series 3 (“TO3”) on January 23, 2024. The new shares and TO3 warrants will be listed on Nasdaq First North Growth Market and the last